Target intelligence / Profile preview

T-cell receptor recognizing MHC-presented Blattella germanica allergen peptide (TCR-MHC-Bla g)

Target
TCR-MHC-Bla g
Molecular classification
Receptor, Immune receptor, Antigen receptor
01

Overview

T-cell receptors (TCRs) recognizing MHC-presented Blattella germanica (German cockroach) allergen peptides are central to the pathogenesis of cockroach-induced allergic diseases (Oseroff et al., 2012, PMID: 22984187). These receptors are expressed on the surface of T lymphocytes and specifically bind to peptide fragments derived from major cockroach allergens, such as Bla g 1, Bla g 2, and Bla g 5, which are presented by Major Histocompatibility Complex (MHC) class II molecules (Pomés et al., 2017, PMID: 28135197). This interaction initiates a Th2-polarized immune response, characterized by the secretion of pro-inflammatory cytokines like IL-4 and IL-13, leading to IgE synthesis and airway hyperresponsiveness (Jeong et al., 2016, PMID: 27126153). In urban environments, exposure to these allergens is a significant risk factor for the development and severity of asthma. Therapeutic interventions targeting this TCR-MHC-peptide complex aim to modulate the immune system through allergen-specific immunotherapy, which seeks to desensitize the patient and induce long-term tolerance. Monitoring TCR specificity and MHC binding affinity is crucial for the design of effective peptide-based vaccines and personalized treatment regimens for cockroach-sensitive individuals.

Other names
Cockroach allergen-specific T-cell receptorBla g-specific TCRGerman cockroach allergen-reactive T-cell receptorT-cell receptor recognizing cockroach allergen peptides
02

Mechanism of action

Induction of immune tolerance through T-cell anergy, clonal deletion, or the promotion of regulatory T cells (Tregs) that suppress Th2-mediated allergic inflammation.

03

Biological functions

Immune responseAntigen recognitionT-cell activationCytokine productionAdaptive immunity
04

Disease associations

AllergyAsthmaInflammationAllergic rhinitis
05

Safety considerations

Risk of anaphylaxis during immunotherapySystemic allergic reactionsPotential for exacerbating acute asthma symptomsInjection site reactions
06

Interacting drugs

Allergen-specific immunotherapy (ASIT)

3 more in the full profile.

07

Biomarkers

Specific IgE (sIgE) levelsTh2 cytokine levels (IL-4, IL-5, IL-13)TCR repertoire diversityMHC class II tetramer bindingBasophil activation test (BAT)

Beyond the preview

Go deeper on T-cell receptor recognizing MHC-presented Blattella germanica allergen peptide (TCR-MHC-Bla g).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell receptor recognizing MHC-presented Blattella germanica allergen peptide (TCR-MHC-Bla g).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call